Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q2

3750.TEDINET S100PLQ1
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥1.3bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥668m2021-04-01 → 2021-09-30Cons.Net sales
Operating income−¥381m2022-04-01 → 2022-09-30Cons.Operating income
Operating income−¥259m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income−¥437m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income−¥418m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥237m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax−¥539m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax−¥47m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)−¥561m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥78m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥34m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income−¥561m2022-04-01 → 2022-09-30Cons.Profit loss
Net income−¥34m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥14.2bnat 2022-09-30Cons.Assets
Total assets¥16.0bnat 2022-03-31Cons.Assets
Total assets¥16.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥11.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥12.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.2bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.7bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥861mat 2022-09-30Cons.Cash and deposits
Cash and deposits¥852mat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥561mat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥702mat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.1bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥20m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥188m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥98m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥94m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥49m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥67m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥36m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥88m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-62.862022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-30.662022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.792021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.92021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.732021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio20.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio21.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.4%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥74m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-09-30−¥119m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-09-30−¥188m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30−¥307m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥76m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2021-04-01 → 2021-09-30¥101m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2021-04-01 → 2021-09-30¥101m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2021-04-01 → 2021-09-30−¥106m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2021-04-01 → 2021-09-30¥568m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2021-04-01 → 2021-09-30¥568m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2021-04-01 → 2021-09-30−¥78m
—segment totalrevenue2021-04-01 → 2021-09-30¥668m
—segment totalrevenue external2021-04-01 → 2021-09-30¥668m
—segment totalsegment profit2021-04-01 → 2021-09-30−¥184m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 449
ItemContextValueUnit
Valuation and translation adjustmentsPrior1YearInstant67000JPY
Valuation and translation adjustmentsCurrentQuarterInstant50000JPY
Subscription rights to sharesPrior1YearInstant211501000JPY
Subscription rights to sharesCurrentQuarterInstant211501000JPY
Non controlling interestsPrior1YearInstant3798000JPY
Non controlling interestsCurrentQuarterInstant3813000JPY
Net assetsPrior1YearInstant3716452000JPY
Net assetsCurrentQuarterInstant3155188000JPY
Liabilities and net assetsPrior1YearInstant16006766000JPY
Liabilities and net assetsCurrentQuarterInstant14239754000JPY
Net salesPrior1YTDDuration668468000JPY
Net salesCurrentYTDDuration1172744000JPY
Cost of salesPrior1YTDDuration322101000JPY
Cost of salesCurrentYTDDuration634678000JPY
Gross profitPrior1YTDDuration346366000JPY
Gross profitCurrentYTDDuration538065000JPY
Salaries and allowances sgaPrior1YTDDuration149642000JPY
Salaries and allowances sgaCurrentYTDDuration202797000JPY
Depreciation sgaPrior1YTDDuration112031000JPY
Depreciation sgaCurrentYTDDuration140627000JPY
Other sgaPrior1YTDDuration344066000JPY
Other sgaCurrentYTDDuration575626000JPY
Selling general and administrative expensesPrior1YTDDuration605739000JPY
Selling general and administrative expensesCurrentYTDDuration919050000JPY
Operating incomePrior1YTDDuration-259373000JPY
Operating incomeCurrentYTDDuration-380985000JPY
Subsidy income noi bountyPrior1YTDDuration43543000JPY
Subsidy income noi bountyCurrentYTDDuration22758000JPY
Other noiPrior1YTDDuration23396000JPY
Other noiCurrentYTDDuration5789000JPY
Non operating incomePrior1YTDDuration66939000JPY
Non operating incomeCurrentYTDDuration28548000JPY
Interest expenses noePrior1YTDDuration41765000JPY
Interest expenses noeCurrentYTDDuration59664000JPY
Arrangement fee noePrior1YTDDuration－JPY
Arrangement fee noeCurrentYTDDuration25000000JPY
Other noePrior1YTDDuration3039000JPY
Other noeCurrentYTDDuration269000JPY
Non operating expensesPrior1YTDDuration44805000JPY
Non operating expensesCurrentYTDDuration84934000JPY
Ordinary incomePrior1YTDDuration-237238000JPY
Ordinary incomeCurrentYTDDuration-437370000JPY
Gain on sales of investment securities eiPrior1YTDDuration85510000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Gain on negative goodwill eiPrior1YTDDuration96181000JPY
Gain on negative goodwill eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration－JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration181692000JPY
Extraordinary incomeCurrentYTDDuration0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass